Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07665372 · ClinicalTrials.gov registry record · NA

Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

A NA study, sponsored by Johns Hopkins University.

Not yet
Registry status
NA
Development phase
80
Enrollment target

NCT07665372: Clinical Trial NA study, sponsored by Johns Hopkins University.

NCT07665372 is a NA study that has not yet begun recruiting, run by Johns Hopkins University. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07665372, a NA study, has not yet begun recruiting, sponsored by Johns Hopkins University.

NOT YET RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

This research is being done to better understand opportunistic infections and cancer in transplant recipients with HIV who receive livers from a donor with HIV compared to livers from donors without HIV.

Primary Outcome

Cumulative incidence of composite event of opportunistic infection or cancer

Interventions

  • OTHER HIV D+/R+
  • OTHER HIV D-/R+

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2026-09
Est. Completion 2031-08
Phase NA
Johns Hopkins University

1,448 total trials

What is known before NCT07665372 opens enrollment

NCT07665372 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which HIV D+/R+ is the first listed.

NCT07665372 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07665372 about?

NCT07665372 is a clinical study titled "Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)". This research is being done to better understand opportunistic infections and cancer in transplant recipients with HIV who receive livers from a donor with HIV compared to livers from donors without HIV.

What is the current status of trial NCT07665372?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-09. Estimated completion is 2031-08.

What interventions are being tested in trial NCT07665372?

The interventions under investigation include: HIV D+/R+ (OTHER), HIV D-/R+ (OTHER).

Who is sponsoring clinical trial NCT07665372?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07665372's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07665372, the US trial registry maintained by the National Library of Medicine. NCT07665372 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.